Answers are grounded in this paper and cite their sources.
The recipients of allogeneic SCT receiving additional pamidronate sustain less bone loss than those treated with calcium, vitamin D, and sex steroid replacement alone. Despite all the efforts, however, bone loss is not totally abolished at the hip.
No takes yet. Share an insight, caveat, or question.
Kananen et al. (2005) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: